Caribou Biosciences Inc. Overview
Caribou Biosciences, Inc., a health care company headquartered in Berkeley, United States, specializes in the development and provision of medical therapies and bio-based products. The company’s offerings include therapeutic bioproduction, microbial strains, and agricultural biotechnology products. Caribou Biosciences markets its products on a global scale, aiming to address various needs within the health care and agricultural sectors.
Financial Performance
As of June 26, 2025, Caribou Biosciences’ stock closed at $1.26 on the Nasdaq exchange. Over the past year, the company’s stock has experienced significant fluctuations. The 52-week high was recorded at $3 on November 6, 2024, while the 52-week low was $0.66 on April 6, 2025. These figures reflect the dynamic nature of the biotechnology sector and the challenges faced by companies within this industry.
Product Offerings and Market Reach
Caribou Biosciences is known for its diverse range of products, which include therapeutic bioproduction solutions, microbial strains, and agricultural biotechnology products. These offerings are designed to meet the needs of various industries, including health care and agriculture. The company’s global marketing strategy allows it to reach a wide audience, enhancing its potential for growth and impact.
Further Information
For more detailed information about Caribou Biosciences’ products, initiatives, and corporate activities, interested parties can visit the company’s website at www.cariboubio.com . The website provides comprehensive insights into the company’s mission, product lines, and ongoing projects.
Caribou Biosciences continues to focus on innovation and development within the health care and agricultural biotechnology sectors, striving to deliver solutions that address critical global challenges.